Delivery Order SPE2DB20D1047-SPE2DB25FF32E

Award Date 12/10/24
Potential Completion Date 12/11/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF32E
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,730.71 Firm Fixed Price Delivery Order covers the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $14,730.71 and an ultimate completion date of December 11, 2024. This appears to be a call order against a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for the DLA and federal healthcare programs, supplying critical pharmaceutical and medical commodities to military treatment facilities, veterans' healthcare, and other federal medical institutions.

Generated 3/11/25, 9:52 AM